文献速递瓣膜病与结构性心脏病

左心室射血分数降低对75岁及以上中重度主动脉瓣狭窄患者全因死亡率的影响

[Impact of reduced left ventricular ejection fraction on all-cause mortality of 75 years old and over patients with moderate to severe aortic stenosis].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2016-01-01

回顾性分析301例≥75岁非风湿性中重度主动脉瓣狭窄患者,按LVEF不同阈值分组随访至2016年1月1日。LVEF≤55%与全因死亡率升高相关(HR=0.568,95%CI 0.340-0.947,P<0.05),但在TAVR和/或SAVR组中LVEF与全因死亡率无关。

要点

  • 在≥75岁中重度主动脉瓣狭窄患者中,LVEF≤55%与全因死亡率升高相关。
  • LVEF≤60%与>60%组间全因死亡率无显著差异。
  • 在TAVR和/或SAVR治疗的患者中,LVEF与全因死亡率无关。

核心结论

  • 在75岁及以上中重度主动脉瓣狭窄患者中,LVEF≤55%与全因死亡率升高相关,而在TAVR和/或SAVR组中LVEF与全因死亡率无关。

研究设计与样本

  • 回顾性分析2008年1月1日至2015年1月1日在本院经超声心动图诊断的非风湿性中重度主动脉瓣狭窄的301例连续≥75岁患者的临床资料。
  • 按LVEF分为正常LVEF组和低LVEF组,低LVEF阈值分别设为≤60%(n=171)vs. >60%(n=130)、≤55%(n=101)vs. >55%(n=200)、≤50%(n=65)vs. >50%(n=236)、≤45%(n=51)vs. >45%(n=250)和≤40%(n=37)vs. >40%(n=264)。
  • 所有患者随访至2016年1月1日,主要终点为全因死亡,采用Log-rank检验比较组间死亡率,多因素Cox回归模型分析全因死亡相关危险因素。

主要发现

  • 随访19(8至37)个月,≤60%组与>60%组死亡率相似(HR=0.741,95%CI 0.457-1.201,P>0.05)。
  • ≤55%组与>55%组(HR=0.524,95%CI 0.329-0.836,P<0.01)、≤50%组与>50%组(HR=0.371,95%CI 0.230-0.600,P<0.01)、≤45%组与>45%组(HR=0.343,95%CI 0.208-0.564,P<0.01)、≤40%组与>40%组(HR=0.321,95%CI 0.188-0.548,P<0.01)死亡率差异均有统计学意义。
  • 在接受保守治疗的患者中,≤60%组与>60%组死亡率相似,但>55%组较≤55%组、>50%组较≤50%组、>45%组较≤45%组、>40%组较≤40%组死亡率均显著降低(均P<0.01)。
  • 在接受TAVR和/或SAVR治疗的患者中,全因死亡率相似。
  • 调整年龄、性别、慢性阻塞性肺疾病、脑血管病和主动脉瓣跨瓣压差后,多因素Cox回归模型显示LVEF>55%组较≤55%组全因死亡风险更低(HR=0.568,95%CI 0.340-0.947,P<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the impact of left ventricular systolic dysfunction on all-cause mortality of 75 years old and over patients with moderate to severe aortic stenosis. Methods: Clinical data of 301 consecutive aged (≥75 years old) patients with a diagnosis of non-rheumatic moderate to severe aortic stenosis by echocardiography between January 1, 2008 and January 1, 2015 in our hospital were retrospectively analyzed. According to the LVEF, patients were divided into normal LVEF subjects and low LVEF subjects, and the low LVEF level was set at below 60%(≤60%(n=171)vs. >60%(n=130)), 55%(≤55%(n=101)vs. >55%(n=200)), 50%(≤50%(n=65)vs. >50%(n=236)), 45%(≤45%(n=51)vs. >45%(n=250)) and 40%(≤40%(n=37)vs. >40%(n=264)), respectively. All patients were followed to January 1, 2016.The primary end point was death from any cause. Log-rank test was used to compare the mortality between groups. Multivariate Cox regression model analysis was used to identify risk factors related to all-cause death. Results: The patients were followed-up 19 (8 to 37) months. The mortality was similar among the ≤60% and >60% groups(HR=0.741, 95%CI 0.457-1.201, P>0.05), but significantly difference was evidenced between the ≤55% and >55%(HR=0.524, 95%CI 0.329-0.836, P<0.01), ≤50% and >50%(HR=0.371, 95%CI 0.230-0.600, P<0.01), ≤45% and >45%(HR=0.343, 95%CI 0.208-0.564, P<0.01), ≤40% and >40% groups(HR=0.321, 95%CI 0.188-0.548, P<0.01). Among patients receiving conservative therapy, mortality was similar between ≤60% and >60% groups, but mortality was significantly lower in >55% group than in ≤55% group, in >50% group than in ≤50% group, in >45% group than in ≤45% group as well as in >40% group than in ≤40% group (all P<0.01). All-cause mortality was similar in patients treated with TAVR and/or SAVR. After adjusting for age, gender, chronic obstruct pulmonary disease, cerebrovascular disease, and aortic valve transaortic pressure gradient, multivariate Cox regression model analysis showed that patients in LVEF>55% group were associated with lower risk of all-cause mortality compared with≤55% group(HR=0.568, 95%CI 0.340-0.947, P<0.05). Conclusions: Among the 75 years old and over patients with moderate to severe aortic stenosis, LVEF≤55% is related to increased all-cause mortality and In TAVR and/or SAVR group, LVEF is not associated with all-cause mortality.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li Z, Ye YQ, Wang MY, et al. [Impact of reduced left ventricular ejection fraction on all-cause mortality of 75 years old and over patients with moderate to severe aortic stenosis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016. PMID: 27903371. doi:10.3760/cma.j.issn.0253-3758.2016.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。